{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:02:15Z","timestamp":1740106935232,"version":"3.37.3"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T00:00:00Z","timestamp":1709337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T00:00:00Z","timestamp":1709337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the National Key Research and Development Program of China","award":["2022YFA1103500"],"award-info":[{"award-number":["2022YFA1103500"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170210"],"award-info":[{"award-number":["82170210"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s00277-024-05658-3","type":"journal-article","created":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T06:01:21Z","timestamp":1709359281000},"page":"1353-1362","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Outcomes of haploidentical peripheral blood stem cell transplantation following myeloablative conditioning using two types of rabbit ATG: a propensity score-matched analysis"],"prefix":"10.1007","volume":"103","author":[{"given":"Zhuoyue","family":"Shi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dang","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hengwei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jimin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yamin","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyu","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lizhen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huarui","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"He","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3857-5574","authenticated-orcid":false,"given":"Yanmin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,2]]},"reference":[{"issue":"6","key":"5658_CR1","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/nri3212","volume":"12","author":"BR Blazar","year":"2012","unstructured":"Blazar BR, Murphy WJ, Abedi M (2012) Advances in graft-versus-host disease biology and therapy. Nat Rev Immunol 12(6):443\u2013458","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"5658_CR2","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1038\/s41409-018-0393-0","volume":"54","author":"A Kumar","year":"2019","unstructured":"Kumar A, Reljic T, Hamadani M, Mohty M, Kharfan-Dabaja MA (2019) Antithymocyte globulin for graft-versus-host disease prophylaxis: an updated systematic review and meta-analysis. Bone Marrow Transplant 54(7):1094\u20131106","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"5658_CR3","doi-asserted-by":"publisher","first-page":"2942","DOI":"10.1182\/blood.V98.10.2942","volume":"98","author":"A Bacigalupo","year":"2001","unstructured":"Bacigalupo A, Lamparelli T, Bruzzi P, Guidi S, Alessandrino PE, di Bartolomeo P, Oneto R, Bruno B, Barbanti M, Sacchi N et al (2001) Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO). Blood 98(10):2942\u20132947","journal-title":"Blood"},{"issue":"2","key":"5658_CR4","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/S1470-2045(15)00462-3","volume":"17","author":"I Walker","year":"2016","unstructured":"Walker I, Panzarella T, Couban S, Couture F, Devins G, Elemary M, Gallagher G, Kerr H, Kuruvilla J, Lee SJ et al (2016) Pretreatment with anti-thymocyte globulin versus no anti-thymocyte globulin in patients with haematological malignancies undergoing haemopoietic cell transplantation from unrelated donors: a randomised, controlled, open-label, phase 3, multicentre trial. Lancet Oncol 17(2):164\u2013173","journal-title":"Lancet Oncol"},{"issue":"1","key":"5658_CR5","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s11684-017-0595-7","volume":"13","author":"M Lv","year":"2019","unstructured":"Lv M, Chang Y, Huang X (2019) Everyone has a donor: contribution of the Chinese experience to global practice of haploidentical hematopoietic stem cell transplantation. Front Med 13(1):45\u201356","journal-title":"Front Med"},{"issue":"17","key":"5658_CR6","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1182\/blood-2014-04-571570","volume":"124","author":"Y Luo","year":"2014","unstructured":"Luo Y, Xiao H, Lai X, Shi J, Tan Y, He J, Xie W, Zheng W, Zhu Y, Ye X et al (2014) T-cell-replete haploidentical HSCT with low-dose anti-T-lymphocyte globulin compared with matched sibling HSCT and unrelated HSCT. Blood 124(17):2735\u20132743","journal-title":"Blood"},{"issue":"2","key":"5658_CR7","doi-asserted-by":"publisher","first-page":"224","DOI":"10.3324\/haematol.2016.148510","volume":"102","author":"F Baron","year":"2017","unstructured":"Baron F, Mohty M, Blaise D, Soci\u00e9 G, Labopin M, Esteve J, Ciceri F, Giebel S, Gorin NC, Savani BN et al (2017) Anti-thymocyte globulin as graft-versus-host disease prevention in the setting of allogeneic peripheral blood stem cell transplantation: a review from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Haematologica 102(2):224\u2013234","journal-title":"Haematologica"},{"issue":"7","key":"5658_CR8","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1038\/sj.leu.2404683","volume":"21","author":"M Mohty","year":"2007","unstructured":"Mohty M (2007) Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond. Leukemia 21(7):1387\u20131394","journal-title":"Leukemia"},{"issue":"12","key":"5658_CR9","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.1111\/ajt.12514","volume":"13","author":"I Popow","year":"2013","unstructured":"Popow I, Leitner J, Grabmeier-Pfistershammer K, Majdic O, Zlabinger GJ, Kundi M, Steinberger P (2013) A comprehensive and quantitative analysis of the major specificities in rabbit antithymocyte globulin preparations. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg 13(12):3103\u20133113","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg"},{"doi-asserted-by":"crossref","unstructured":"Oostenbrink LVE, Jol-van der Zijde CM, Kielsen K, Jansen-Hoogendijk AM, Ifversen M, M\u00fcller KG, Lankester AC, van Halteren AGS, Bredius RGM, Schilham MW et al: Differential elimination of anti-thymocyte globulin of fresenius and genzyme impacts T-cell reconstitution after hematopoietic stem cell transplantation. Front Immunol 2019, 10:315.","key":"5658_CR10","DOI":"10.3389\/fimmu.2019.00315"},{"issue":"3","key":"5658_CR11","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/bmt.2013.191","volume":"49","author":"Y Wang","year":"2014","unstructured":"Wang Y, Fu HX, Liu DH, Xu LP, Zhang XH, Chang YJ, Chen YH, Wang FR, Sun YQ, Tang FF et al (2014) Influence of two different doses of antithymocyte globulin in patients with standard-risk disease following haploidentical transplantation: a randomized trial. Bone Marrow Transplant 49(3):426\u2013433","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"5658_CR12","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/S1470-2045(17)30417-5","volume":"18","author":"F Locatelli","year":"2017","unstructured":"Locatelli F, Bernardo ME, Bertaina A, Rognoni C, Comoli P, Rovelli A, Pession A, Fagioli F, Favre C, Lanino E et al (2017) Efficacy of two different doses of rabbit anti-T-lymphocyte globulin to prevent graft-versus-host disease in children with haematological malignancies transplanted from an unrelated donor: a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol 18(8):1126\u20131136","journal-title":"Lancet Oncol"},{"issue":"2","key":"5658_CR13","doi-asserted-by":"publisher","first-page":"e100","DOI":"10.1016\/S2352-3026(19)30220-0","volume":"7","author":"I Walker","year":"2020","unstructured":"Walker I, Panzarella T, Couban S, Couture F, Devins G, Elemary M, Gallagher G, Kerr H, Kuruvilla J, Lee SJ et al (2020) Addition of anti-thymocyte globulin to standard graft-versus-host disease prophylaxis versus standard treatment alone in patients with haematological malignancies undergoing transplantation from unrelated donors: final analysis of a randomised, open-label, multicentre, phase 3 trial. Lancet Haematol 7(2):e100\u2013e111","journal-title":"Lancet Haematol"},{"issue":"29","key":"5658_CR14","doi-asserted-by":"publisher","first-page":"3367","DOI":"10.1200\/JCO.20.00150","volume":"38","author":"YJ Chang","year":"2020","unstructured":"Chang YJ, Wu DP, Lai YR, Liu QF, Sun YQ, Hu J, Hu Y, Zhou JF, Li J, Wang SQ et al (2020) Antithymocyte globulin for matched sibling donor transplantation in patients with hematologic malignancies: a multicenter, open-label, randomized controlled study. J Clin Oncol : official J Am Soc Clin Oncol 38(29):3367\u20133376","journal-title":"J Clin Oncol : official J Am Soc Clin Oncol"},{"issue":"10","key":"5658_CR15","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1038\/s41409-019-0502-8","volume":"54","author":"Y Luo","year":"2019","unstructured":"Luo Y, Jin M, Tan Y, Zhao Y, Shi J, Zhu Y, Zheng W, Lai X, Yu J, Huang H (2019) Antithymocyte globulin improves GVHD-free and relapse-free survival in unrelated hematopoietic stem cell transplantation. Bone Marrow Transplant 54(10):1668\u20131675","journal-title":"Bone Marrow Transplant"},{"key":"5658_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.614488","volume":"11","author":"Y Zhao","year":"2020","unstructured":"Zhao Y, Gao F, Wu Y, Shi J, Luo Y, Tan Y, Yu J, Lai X, Zhang M, Zhang W et al (2020) Decreased iKIR-HLA C pair confers worse clinical outcomes for patients with myeloid disease receiving antithymocyte globulin-based haploidentical hematopoietic stem cell transplantation. Front Immunol 11:614488","journal-title":"Front Immunol"},{"issue":"1","key":"5658_CR17","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s12916-019-1393-7","volume":"17","author":"R Lin","year":"2019","unstructured":"Lin R, Wang Y, Huang F, Fan Z, Zhang S, Yang T, Xu Y, Xu N, Xuan L, Ye J et al (2019) Two dose levels of rabbit antithymocyte globulin as graft-versus-host disease prophylaxis in haploidentical stem cell transplantation: a multicenter randomized study. BMC Med 17(1):156","journal-title":"BMC Med"},{"issue":"5","key":"5658_CR18","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/ajh.25417","volume":"94","author":"XS Zhao","year":"2019","unstructured":"Zhao XS, Liu YR, Xu LP, Wang Y, Zhang XH, Chen H, Chen YH, Han W, Sun YQ, Yan CH et al (2019) Minimal residual disease status determined by multiparametric flow cytometry pretransplantation predicts the outcome of patients with ALL receiving unmanipulated haploidentical allografts. Am J Hematol 94(5):512\u2013521","journal-title":"Am J Hematol"},{"issue":"9","key":"5658_CR19","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1016\/j.bbmt.2019.05.036","volume":"25","author":"Y Zhao","year":"2019","unstructured":"Zhao Y, Gao F, Shi J, Luo Y, Tan Y, Lai X, Yu J, Huang H (2019) Incidence, risk factors, and outcomes of primary poor graft function after allogeneic hematopoietic stem Cell Transplantation. Biol Blood Marrow Transplant 25(9):1898\u20131907","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"5658_CR20","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.bbmt.2015.09.001","volume":"22","author":"AC Harris","year":"2016","unstructured":"Harris AC, Young R, Devine S, Hogan WJ, Ayuk F, Bunworasate U, Chanswangphuwana C, Efebera YA, Holler E, Litzow M et al (2016) International, multicenter standardization of acute graft-versus-host disease clinical data collection: a report from the Mount Sinai Acute GVHD International Consortium. Biol Blood Marrow Transpl\u202f:J Am Soc Blood Marrow Transpl 22(1):4\u201310","journal-title":"Biol Blood Marrow Transpl :J Am Soc Blood Marrow Transpl"},{"issue":"31","key":"5658_CR21","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","volume":"21","author":"MH Jagasia","year":"2015","unstructured":"Jagasia MH, Greinix HT, Arora M, Williams KM, Wolff D, Cowen EW, Palmer J, Weisdorf D, Treister NS, Cheng GS et al (2015) National Institutes of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 Diagnosis and Staging Working Group report. Biol Blood Marrow Transpl\u202f:J Am Soc Blood Marrow Transpl 21(31):389-401.e381","journal-title":"Biol Blood Marrow Transpl :J Am Soc Blood Marrow Transpl"},{"issue":"23","key":"5658_CR22","doi-asserted-by":"publisher","first-page":"3664","DOI":"10.1182\/blood-2014-01-552984","volume":"123","author":"P Armand","year":"2014","unstructured":"Armand P, Kim HT, Logan BR, Wang Z, Alyea EP, Kalaycio ME, Maziarz RT, Antin JH, Soiffer RJ, Weisdorf DJ et al (2014) Validation and refinement of the disease risk index for allogeneic stem cell transplantation. Blood 123(23):3664\u20133671","journal-title":"Blood"},{"issue":"19","key":"5658_CR23","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1002\/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B","volume":"17","author":"RB D'Agostino Jr","year":"1998","unstructured":"D\u2019Agostino RB Jr (1998) Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 17(19):2265\u20132281","journal-title":"Stat Med"},{"issue":"6","key":"5658_CR24","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1038\/s41409-020-0792-x","volume":"55","author":"F Bonifazi","year":"2020","unstructured":"Bonifazi F, Rubio MT, Bacigalupo A, Boelens JJ, Finke J, Greinix H, Mohty M, Nagler A, Passweg J, Rambaldi A et al (2020) Rabbit ATG\/ATLG in preventing graft-versus-host disease after allogeneic stem cell transplantation: consensus-based recommendations by an international expert panel. Bone Marrow Transplant 55(6):1093\u20131102","journal-title":"Bone Marrow Transplant"},{"issue":"11","key":"5658_CR25","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1007\/s00432-014-1742-z","volume":"140","author":"A Mensen","year":"2014","unstructured":"Mensen A, Na IK, H\u00e4fer R, Meerbach A, Schlecht M, Pietschmann ML, Gruhn B (2014) Comparison of different rabbit ATG preparation effects on early lymphocyte subset recovery after allogeneic HSCT and its association with EBV-mediated PTLD. J Cancer Res Clin Oncol 140(11):1971\u20131980","journal-title":"J Cancer Res Clin Oncol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-05658-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-024-05658-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-05658-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T10:09:26Z","timestamp":1710410966000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-024-05658-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,2]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["5658"],"URL":"https:\/\/doi.org\/10.1007\/s00277-024-05658-3","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"type":"print","value":"0939-5555"},{"type":"electronic","value":"1432-0584"}],"subject":[],"published":{"date-parts":[[2024,3,2]]},"assertion":[{"value":"21 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the ethics committee of the First Affiliated Hospital of Zhejiang University School of Medicine and in accordance with the Declaration of Helsinki. All patients provided informed consent for retrospective research involving their clinical treatment history.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}